Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rod Dunbar

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|September 24, 2004
Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrenceCaroline L Smith, P Rod Dunbar, Fareed Mirza, et al.
Frontiers in Immunology|June 21, 2024
Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factorsSaem Mul Park, Chun-Jen J Chen, Daniel J Verdon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapyNina Dickgreber, Patrizia Stoitzner, Yan Bai, et al.
Immunology and Cell Biology|June 16, 2016
Plasmin and regulators of plasmin activity control the migratory capacity and adhesion of human T cells and dendritic cells by regulating cleavage of the chemokine CCL21Natalie Lorenz, Evert Jan Loef, Inken D Kelch, et al.
Tissue Engineering. Part A|January 22, 2015
In vitro evaluation of a novel non-mulberry silk scaffold for use in tendon regenerationDavid S Musson, Dorit Naot, Ashika Chhana, et al.
Journal for Immunotherapy of Cancer|April 11, 2024
Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumorsJared M Odegard, Ahmed A Othman, Kai-Wen Lin, et al.
Frontiers in Immunology|February 17, 2025
A novel approach to digital characterisation of Tertiary Lymphoid Structures in colorectal cancerLuis Munoz-Erazo, Saem Mul Park, Shelly Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Competition between CTL narrows the immune response induced by prime-boost vaccination protocolsMichael J Palmowski, Ed Man-Lik Choi, Ian F Hermans, et al.
Immunology and Cell Biology|August 3, 2020
Migratory cues controlling B-lymphocyte trafficking in human lymph nodesSaem Mul Park, Anna Es Brooks, Chun-Jen J Chen, et al.
European Journal of Immunology|April 13, 2007
Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant regionLinda Wooldridge, Anna Lissina, Jonathan Vernazza, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|September 24, 2004
Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrenceCaroline L Smith, P Rod Dunbar, Fareed Mirza, et al.
Frontiers in Immunology|June 21, 2024
Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factorsSaem Mul Park, Chun-Jen J Chen, Daniel J Verdon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapyNina Dickgreber, Patrizia Stoitzner, Yan Bai, et al.
Immunology and Cell Biology|June 16, 2016
Plasmin and regulators of plasmin activity control the migratory capacity and adhesion of human T cells and dendritic cells by regulating cleavage of the chemokine CCL21Natalie Lorenz, Evert Jan Loef, Inken D Kelch, et al.
Tissue Engineering. Part A|January 22, 2015
In vitro evaluation of a novel non-mulberry silk scaffold for use in tendon regenerationDavid S Musson, Dorit Naot, Ashika Chhana, et al.
Journal for Immunotherapy of Cancer|April 11, 2024
Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumorsJared M Odegard, Ahmed A Othman, Kai-Wen Lin, et al.
Frontiers in Immunology|February 17, 2025
A novel approach to digital characterisation of Tertiary Lymphoid Structures in colorectal cancerLuis Munoz-Erazo, Saem Mul Park, Shelly Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Competition between CTL narrows the immune response induced by prime-boost vaccination protocolsMichael J Palmowski, Ed Man-Lik Choi, Ian F Hermans, et al.
Immunology and Cell Biology|August 3, 2020
Migratory cues controlling B-lymphocyte trafficking in human lymph nodesSaem Mul Park, Anna Es Brooks, Chun-Jen J Chen, et al.
European Journal of Immunology|April 13, 2007
Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant regionLinda Wooldridge, Anna Lissina, Jonathan Vernazza, et al.
Pageof 10